DEA Whistleblower Alleges Agency Allowed Fentanyl Distribution in New Mexico

UNVERIFIED·Primary source · AP News

DEA Special Agent David Howell filed a whistleblower complaint alleging the agency allowed hundreds of thousands of fentanyl pills to be distributed in New Mexico. The agency claimed the strategy was to build larger federal prosecutions, a practice known as 'walking' drugs. The Justice Department's Office of Professional Responsibility found the DEA's actions reasonable and not a danger to public health.

Key Facts

01 — What / Thesis
DEA Whistleblower Alleges Agency Allowed Fentanyl Distribution in New Mexico
02 — Who / Subject
David Howell (DEA Special Agent)
03 — Where / Locus
Albuquerque, New Mexico, USA
04 — When / Temporality
Late 2023 to June 2026

AI Verification Note

This article is generated by cross-referencing multiple sources and official announcements. Parts relying solely on testimony or reporting are reflected in the confidence score; content and assessment are updated as new information is confirmed.

Recommended Background Resource

Affiliate / AdAI Curation

Drug War Capitalism

Author: Dawn Paley

This book provides a critical analysis of how drug enforcement policies, including controversial tactics like 'controlled deliveries' or 'drug walking,' often serve broader geopolitical and institutional interests rather than public safety, mirroring the systemic issues raised by the DEA whistleblower.

Explore Background Book (Amazon)

As an Amazon Associate, COMPAMIR earns from qualifying purchases.

Post